<rp id="e1j8h"></rp>

            <rp id="e1j8h"></rp>

              1.   Їf

                The Sino-Australian Symposium on Cancer Care was successfully held during 2022 Chinese Congress on Oncology in Hangzhou

                The Sino-Australian Symposium on Cancer Care was successfully held during 2022 Chinese Congress on Oncology in Hangzhou

                On November 20th, 2022, the Sino-Australian Symposium on Cancer Care co-organized by the China Anti-Cancer Association (CACA), Chinese Anti-Cancer Association Australia (CACA Australia), and Icon Group, was successfully held during 2022 Chinese Congress on Oncology (CCO) in Hangzhou, Zhejiang province. The symposium was in a hybrid form with both onsite and virtual participants, and attracted great attention with 64,300 live viewers. It focused on the latest developments in precision prevention and control as well as integrative treatment of tumors together with innovative applications in the training of cancer care.

                Prof. Ying Wang, General Secretary of CACA, delivered a welcome speech on behalf of CACA to express her heartfelt thanks to CACA Australia and Icon Group, the co-organizers of the conference, warmly welcome all the audience who attended the conference online and onsite, and wish the conference a great success.

                Prof. Xueqin Yu, President of CACA Australia also gave a welcome remark and said that it was very meaningful to hold the Sino-Australian Symposium during CCO, and he hoped that CACA Australia could co-organize more academic conferences with CACA.

                Mark Middleton, CEO of Icon Group, said in his speech that CACA is a very important partner of Icon Group and has made outstanding contributions to global cancer control, and he hoped that the two sides could continue cooperating in the future.

                The symposium included three sessions, and the first one was hosted by Prof. Yaping Liu, Vice President and Secretary General of CACA Australia, and Research Fellow of Australasian College of Health Service Management.

                “Precision prevention of gastric cancer in a high-risk area of China” presented by Prof. Wenqing Li, Associate Director of the Center for Clinical Epidemiology, Peking University Cancer Hospital & Institute.

                “Associations between household air pollution, second-hand tobacco smoke and lung cancer mortality among 323,794 Chinese never-smokers: findings from the China Kadoorie Biobank” presented by Dr. Elvin Cheng from the University of Sydney.

                “Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: a single center experience of 93 cases” presented by Dr. Yiming Zhou, Associate Chief Surgeon of the Division of Gastrointestinal & Colorectal Surgery, Department of General Surgery, Huashan Hospital, Fudan University.

                The second session was hosted by Prof. Le Jian, Director and Strategy Advisor for CACA Australia, Adjunct Professor at Curtin University, and Vice President of the Western Australian Chinese Scientists Association.

                “Towards the pan-cancer-associated long non-coding RNA world” presented by Dr. Lei Jin, Investigator Fellow of National Health and Medical Research Council (NHMRC) and Associate Professor at the University of Newcastle.

                “Optimal post-treatment surveillance strategy for nasopharyngeal carcinoma survivors based on the individualized risk-based approach” presented by Dr. Guanqun Zhou, Deputy Chief Physician of the Department of Radiation Oncology, Cancer Center, Sun Yat-sen University

                “Microbiome and cancer” presented by Dr. Mark Wong, Deputy Chair of the clinical cancer trial network steering committee of Sydney West Local Health District (SWLHD) and Honorary Clinical Associate Professor at Macquarie University.

                The third session was hosted by Ning Yang, Vice Director of the Department of Scientific Research and Director of the Office of International Cooperation & Exchange at Zhejiang Cancer Hospital.

                Four experts from Icon Group, namely Darien Montgomerie, Aidan Leong, Leisa Brown, and Keira Plon discussed the topics of “Using technology to deliver remote training in and between Australia, New Zealand and China” and “Multi-disciplinary perspectives: radiation therapy, oncology nursing, chemotherapy compounding”.

                The symposium brought together experts from China and Australia to discuss and share the latest clinical treatment and research progress on cancer care both in China and Australia. It not only focused on the sharing of knowledge about tumor prevention and treatment, but also on the standardization of cancer care, with a view to enabling tumor clinicians and nursing staff to improve their professional skills, learn about the international cutting-edge information, and apply the latest technology to clinical practice for the benefit of Chinese and foreign cancer patients.

                Copyright @ 2009 Chinese Anti-Cancer Association